BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25711212)

  • 21. Hsp90 inhibitor HSP990 in very low dose upregulates EAAT2 and exerts potent antiepileptic activity.
    Sha L; Chen T; Deng Y; Du T; Ma K; Zhu W; Shen Y; Xu Q
    Theranostics; 2020; 10(18):8415-8429. PubMed ID: 32724478
    [No Abstract]   [Full Text] [Related]  

  • 22. Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.
    Woltjer RL; Duerson K; Fullmer JM; Mookherjee P; Ryan AM; Montine TJ; Kaye JA; Quinn JF; Silbert L; Erten-Lyons D; Leverenz JB; Bird TD; Pow DV; Tanaka K; Watson GS; Cook DG
    J Neuropathol Exp Neurol; 2010 Jul; 69(7):667-76. PubMed ID: 20535038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer's disease.
    Becerril-Ortega J; Bordji K; Fréret T; Rush T; Buisson A
    Neurobiol Aging; 2014 Oct; 35(10):2288-301. PubMed ID: 24863668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disrupted cross-laminar cortical processing in β amyloid pathology precedes cell death.
    Lison H; Happel MF; Schneider F; Baldauf K; Kerbstat S; Seelbinder B; Schneeberg J; Zappe M; Goldschmidt J; Budinger E; Schröder UH; Ohl FW; Schilling S; Demuth HU; Scheich H; Reymann KG; Rönicke R
    Neurobiol Dis; 2014 Mar; 63():62-73. PubMed ID: 24291517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraneuronal Aβ as a trigger for neuron loss: can this be translated into human pathology?
    Bayer TA; Wirths O
    Biochem Soc Trans; 2011 Aug; 39(4):857-61. PubMed ID: 21787313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid-β dimers in the absence of plaque pathology impair learning and synaptic plasticity.
    Müller-Schiffmann A; Herring A; Abdel-Hafiz L; Chepkova AN; Schäble S; Wedel D; Horn AH; Sticht H; de Souza Silva MA; Gottmann K; Sergeeva OA; Huston JP; Keyvani K; Korth C
    Brain; 2016 Feb; 139(Pt 2):509-25. PubMed ID: 26657517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
    J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicity.
    Karki P; Smith K; Johnson J; Aschner M; Lee EY
    Neurochem Res; 2015 Feb; 40(2):380-8. PubMed ID: 25064045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reelin delays amyloid-beta fibril formation and rescues cognitive deficits in a model of Alzheimer's disease.
    Pujadas L; Rossi D; Andrés R; Teixeira CM; Serra-Vidal B; Parcerisas A; Maldonado R; Giralt E; Carulla N; Soriano E
    Nat Commun; 2014 Mar; 5():3443. PubMed ID: 24599114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation.
    Zheng W; Xin N; Chi ZH; Zhao BL; Zhang J; Li JY; Wang ZY
    FASEB J; 2009 Dec; 23(12):4207-17. PubMed ID: 19679638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's disease.
    Fernandez-Martos CM; King AE; Atkinson RA; Woodhouse A; Vickers JC
    Neurobiol Aging; 2015 Oct; 36(10):2757-67. PubMed ID: 26344875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained Alzheimer's amyloid pathology in myeloid differentiation protein-88-deficient APPswe/PS1 mice.
    Goll Y; Bekenstein U; Barbash S; Greenberg DS; Zangen R; Shoham S; Soreq H
    Neurodegener Dis; 2014; 13(2-3):58-60. PubMed ID: 24192711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer's disease.
    Kumar S; Wirths O; Theil S; Gerth J; Bayer TA; Walter J
    Acta Neuropathol; 2013 May; 125(5):699-709. PubMed ID: 23525537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pyridazine-derivatives Enhance Structural and Functional Plasticity of Tripartite Synapse Via Activation of Local Translation in Astrocytic Processes.
    Foster JB; Zhao F; Wang X; Xu Z; Lin K; Askwith CC; Hodgetts KJ; Lin CG
    Neuroscience; 2018 Sep; 388():224-238. PubMed ID: 30056115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators.
    Xing X; Chang LC; Kong Q; Colton CK; Lai L; Glicksman MA; Lin CL; Cuny GD
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5774-7. PubMed ID: 21875806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of translational activators of glial glutamate transporter EAAT2 through cell-based high-throughput screening: an approach to prevent excitotoxicity.
    Colton CK; Kong Q; Lai L; Zhu MX; Seyb KI; Cuny GD; Xian J; Glicksman MA; Lin CL
    J Biomol Screen; 2010 Jul; 15(6):653-62. PubMed ID: 20508255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.